Correlation Between Dupont De and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dupont De and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Kymera Therapeutics, you can compare the effects of market volatilities on Dupont De and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Kymera Therapeutics.
Diversification Opportunities for Dupont De and Kymera Therapeutics
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Dupont and Kymera is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Dupont De and Kymera Therapeutics
Allowing for the 90-day total investment horizon Dupont De is expected to generate 5.77 times less return on investment than Kymera Therapeutics. But when comparing it to its historical volatility, Dupont De Nemours is 3.85 times less risky than Kymera Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 3,914 in Kymera Therapeutics on October 20, 2024 and sell it today you would earn a total of 147.00 from holding Kymera Therapeutics or generate 3.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dupont De Nemours vs. Kymera Therapeutics
Performance |
| Timeline |
| Dupont De Nemours |
| Kymera Therapeutics |
Dupont De and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Kymera Therapeutics
The main advantage of trading using opposite Dupont De and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Dupont De vs. Eastman Chemical | Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |